However, CD69, CD73 or Ki-67 staining of CD19+ B cell follicles did not indicate increased germinal center formation or activity in the lymph nodes upon combination therapy compared with other groups of tumor-bearing mice (Fig. 5). The gene discussed is CD69; the disease is neoplasm.